Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Protagonist Therapeutics, Inc (PTGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Protagonist Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
07/05/2023 8-K Quarterly results
07/03/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/30/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/04/2023 8-K Quarterly results
Docs: "Protagonist Reports First Quarter 2023 Financial Results and Provides Corporate Update"
03/15/2023 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
01/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/08/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
04/26/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis",
"943 Phase 2 Study Data Readout Dinesh V. Patel, PhD"
04/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "COMPANY OVERVIEW Dinesh V. Patel, PhD"
03/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/28/2022 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update"
02/22/2022 8-K Quarterly results
11/03/2021 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update"
09/17/2021 8-K Quarterly results
08/10/2021 8-K Entry into a Material Definitive Agreement  Interactive Data
08/04/2021 8-K Quarterly results
07/28/2021 8-K Entry into a Material Definitive Agreement  Interactive Data
06/17/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
05/28/2021 8-K Quarterly results
05/04/2021 8-K Quarterly results
03/10/2021 8-K Quarterly results
12/11/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement",
"Opinion of Cooley LLP"
11/04/2020 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update",
"Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology 2020 Annual Meeting"
10/02/2020 8-K/A Quarterly results
09/11/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Protagonist Therapeutics, Inc. PTG-300 Opportunity Update Presentation"
08/13/2020 8-K Quarterly results
08/06/2020 8-K Quarterly results
05/29/2020 8-K Submission of Matters to a Vote of Security Holders
05/12/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy